This report studies the global Female Contraception Drug market status and forecast, categorizes the global Female Contraception Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
In 2020, the global Female Contraception Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx.x % between 2021 and 2027.
The major players covered in this report
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
AG-890
Amphora
BAY-1007626
Drospirenone
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinic
Hospital
Homecare
The study objectives of this report are:
To analyze and study the global Female Contraception Drug sales, value, status (2016-2020) and forecast (2021-2027);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Female Contraception Drug players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Female Contraception Drug are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Female Contraception Drug Manufacturers
Female Contraception Drug Distributors/Traders/Wholesalers
Female Contraception Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Female Contraception Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Female Contraception Drug Sales Market Report 2021
1 Female Contraception Drug Market Overview
1.1 Product Overview and Scope of Female Contraception Drug
1.2 Classification of Female Contraception Drug by Product Category
1.2.1 Global Female Contraception Drug Market Size (Sales) Comparison by Type ( 2016-2027)
1.2.2 Global Female Contraception Drug Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 AG-890
1.2.4 Amphora
1.2.5 BAY-1007626
1.2.6 Drospirenone
1.2.7 Others
1.3 Global Female Contraception Drug Market by Application/End Users
1.3.1 Global Female Contraception Drug Sales (Volume) and Market Share Comparison by Application ( 2016-2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market by Region
1.4.1 Global Female Contraception Drug Market Size (Value) Comparison by Region ( 2016-2027)
1.4.2 United States Female Contraception Drug Status and Prospect ( 2016-2027)
1.4.3 Europe Female Contraception Drug Status and Prospect ( 2016-2027)
1.4.4 China Female Contraception Drug Status and Prospect ( 2016-2027)
1.4.5 Japan Female Contraception Drug Status and Prospect ( 2016-2027)
1.4.6 Southeast Asia Female Contraception Drug Status and Prospect ( 2016-2027)
1.4.7 India Female Contraception Drug Status and Prospect ( 2016-2027)
1.5 Global Market Size (Value and Volume) of Female Contraception Drug ( 2016-2027)
1.5.1 Global Female Contraception Drug Sales and Growth Rate ( 2016-2027)
1.5.2 Global Female Contraception Drug Revenue and Growth Rate ( 2016-2027)
2 Global Female Contraception Drug Competition by Players/Suppliers, Type and Application
2.1 Global Female Contraception Drug Market Competition by Players/Suppliers
2.1.1 Global Female Contraception Drug Sales and Market Share of Key Players/Suppliers ( 2016-2021)
2.1.2 Global Female Contraception Drug Revenue and Share by Players/Suppliers ( 2016-2021)
2.2 Global Female Contraception Drug (Volume and Value) by Type
2.2.1 Global Female Contraception Drug Sales and Market Share by Type ( 2016-2021)
2.2.2 Global Female Contraception Drug Revenue and Market Share by Type ( 2016-2021)
2.3 Global Female Contraception Drug (Volume and Value) by Region
2.3.1 Global Female Contraception Drug Sales and Market Share by Region ( 2016-2021)
2.3.2 Global Female Contraception Drug Revenue and Market Share by Region ( 2016-2021)
2.4 Global Female Contraception Drug (Volume) by Application
3 United States Female Contraception Drug (Volume, Value and Sales Price)
3.1 United States Female Contraception Drug Sales and Value ( 2016-2021)
3.1.1 United States Female Contraception Drug Sales and Growth Rate ( 2016-2021)
3.1.2 United States Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
3.1.3 United States Female Contraception Drug Sales Price Trend ( 2016-2021)
3.2 United States Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
3.3 United States Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
3.4 United States Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
4 Europe Female Contraception Drug (Volume, Value and Sales Price)
4.1 Europe Female Contraception Drug Sales and Value ( 2016-2021)
4.1.1 Europe Female Contraception Drug Sales and Growth Rate ( 2016-2021)
4.1.2 Europe Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
4.1.3 Europe Female Contraception Drug Sales Price Trend ( 2016-2021)
4.2 Europe Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
4.3 Europe Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
4.4 Europe Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
5 China Female Contraception Drug (Volume, Value and Sales Price)
5.1 China Female Contraception Drug Sales and Value ( 2016-2021)
5.1.1 China Female Contraception Drug Sales and Growth Rate ( 2016-2021)
5.1.2 China Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
5.1.3 China Female Contraception Drug Sales Price Trend ( 2016-2021)
5.2 China Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
5.3 China Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
5.4 China Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
6 Japan Female Contraception Drug (Volume, Value and Sales Price)
6.1 Japan Female Contraception Drug Sales and Value ( 2016-2021)
6.1.1 Japan Female Contraception Drug Sales and Growth Rate ( 2016-2021)
6.1.2 Japan Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
6.1.3 Japan Female Contraception Drug Sales Price Trend ( 2016-2021)
6.2 Japan Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
6.3 Japan Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
6.4 Japan Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
7 Southeast Asia Female Contraception Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Female Contraception Drug Sales and Value ( 2016-2021)
7.1.1 Southeast Asia Female Contraception Drug Sales and Growth Rate ( 2016-2021)
7.1.2 Southeast Asia Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
7.1.3 Southeast Asia Female Contraception Drug Sales Price Trend ( 2016-2021)
7.2 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
7.3 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
7.4 Southeast Asia Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
8 India Female Contraception Drug (Volume, Value and Sales Price)
8.1 India Female Contraception Drug Sales and Value ( 2016-2021)
8.1.1 India Female Contraception Drug Sales and Growth Rate ( 2016-2021)
8.1.2 India Female Contraception Drug Revenue and Growth Rate ( 2016-2021)
8.1.3 India Female Contraception Drug Sales Price Trend ( 2016-2021)
8.2 India Female Contraception Drug Sales Volume and Market Share by Players ( 2016-2021)
8.3 India Female Contraception Drug Sales Volume and Market Share by Type ( 2016-2021)
8.4 India Female Contraception Drug Sales Volume and Market Share by Application ( 2016-2021)
9 Global Female Contraception Drug Players/Suppliers Profiles and Sales Data
9.1 Addex Therapeutics Ltd
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Female Contraception Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.1.4 Main Business/Business Overview
9.2 Agile Therapeutics Inc
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Female Contraception Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.2.4 Main Business/Business Overview
9.3 Bayer AG
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Female Contraception Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Bayer AG Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.3.4 Main Business/Business Overview
9.4 Evofem Inc
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Female Contraception Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Evofem Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.4.4 Main Business/Business Overview
9.5 Hervana Ltd
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Female Contraception Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.5.4 Main Business/Business Overview
9.6 Mithra Pharmaceuticals SA
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Female Contraception Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.6.4 Main Business/Business Overview
9.7 Orbis Biosciences Inc
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Female Contraception Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.7.4 Main Business/Business Overview
9.8 Teva Pharmaceutical Industries Ltd
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Female Contraception Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.8.4 Main Business/Business Overview
9.9 Viramal Ltd
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Female Contraception Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin ( 2016-2021)
9.9.4 Main Business/Business Overview
10 Female Contraception Drug Maufacturing Cost Analysis
10.1 Female Contraception Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Female Contraception Drug
10.3 Manufacturing Process Analysis of Female Contraception Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Female Contraception Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2020
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Female Contraception Drug Market Forecast ( 2021-2027)
14.1 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast ( 2021-2027)
14.1.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast ( 2021-2027)
14.1.2 Global Female Contraception Drug Revenue and Growth Rate Forecast ( 2021-2027)
14.1.3 Global Female Contraception Drug Price and Trend Forecast ( 2021-2027)
14.2 Global Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast by Region ( 2021-2027)
14.2.1 Global Female Contraception Drug Sales Volume and Growth Rate Forecast by Regions ( 2021-2027)
14.2.2 Global Female Contraception Drug Revenue and Growth Rate Forecast by Regions ( 2021-2027)
14.2.3 United States Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.2.4 Europe Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.2.5 China Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.2.6 Japan Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.2.7 Southeast Asia Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.2.8 India Female Contraception Drug Sales Volume, Revenue and Growth Rate Forecast ( 2021-2027)
14.3 Global Female Contraception Drug Sales Volume, Revenue and Price Forecast by Type ( 2021-2027)
14.3.1 Global Female Contraception Drug Sales Forecast by Type ( 2021-2027)
14.3.2 Global Female Contraception Drug Revenue Forecast by Type ( 2021-2027)
14.3.3 Global Female Contraception Drug Price Forecast by Type ( 2021-2027)
14.4 Global Female Contraception Drug Sales Volume Forecast by Application ( 2021-2027)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Female Contraception Drug
Figure Global Female Contraception Drug Sales Volume Comparison (K Pcs) by Type ( 2016-2027)
Figure Global Female Contraception Drug Sales Volume Market Share by Type (Product Category) in 2020
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Figure Global Female Contraception Drug Sales Comparison (K Pcs) by Application ( 2016-2027)
Figure Global Sales Market Share of Female Contraception Drug by Application in 2020
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure Global Female Contraception Drug Market Size (Million USD) by Regions ( 2016-2027)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Europe Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure China Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Japan Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Southeast Asia Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure India Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Global Female Contraception Drug Sales Volume (K Pcs) and Growth Rate ( 2016-2027)
Figure Global Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2027)
Figure Global Market Major Players Female Contraception Drug Sales Volume (K Pcs) ( 2016-2021)
Table Global Female Contraception Drug Sales (K Pcs) of Key Players/Suppliers ( 2016-2021)
Table Global Female Contraception Drug Sales Share by Players/Suppliers ( 2016-2021)
Figure 2020 Female Contraception Drug Sales Share by Players/Suppliers
Figure 2020 Female Contraception Drug Sales Share by Players/Suppliers
Figure Global Female Contraception Drug Revenue (Million USD) by Players/Suppliers ( 2016-2021)
Table Global Female Contraception Drug Revenue (Million USD) by Players/Suppliers ( 2016-2021)
Table Global Female Contraception Drug Revenue Share by Players/Suppliers ( 2016-2021)
Table 2020 Global Female Contraception Drug Revenue Share by Players
Table 2020 Global Female Contraception Drug Revenue Share by Players
Table Global Female Contraception Drug Sales (K Pcs) and Market Share by Type ( 2016-2021)
Table Global Female Contraception Drug Sales Share (K Pcs) by Type ( 2016-2021)
Figure Sales Market Share of Female Contraception Drug by Type ( 2016-2021)
Figure Global Female Contraception Drug Sales Growth Rate by Type ( 2016-2021)
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Type ( 2016-2021)
Table Global Female Contraception Drug Revenue Share by Type ( 2016-2021)
Figure Revenue Market Share of Female Contraception Drug by Type ( 2016-2021)
Figure Global Female Contraception Drug Revenue Growth Rate by Type ( 2016-2021)
Table Global Female Contraception Drug Sales Volume (K Pcs) and Market Share by Region ( 2016-2021)
Table Global Female Contraception Drug Sales Share by Region ( 2016-2021)
Figure Sales Market Share of Female Contraception Drug by Region ( 2016-2021)
Figure Global Female Contraception Drug Sales Growth Rate by Region in 2020
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Region ( 2016-2021)
Table Global Female Contraception Drug Revenue Share (%) by Region ( 2016-2021)
Figure Revenue Market Share of Female Contraception Drug by Region ( 2016-2021)
Figure Global Female Contraception Drug Revenue Growth Rate by Region in 2020
Table Global Female Contraception Drug Revenue (Million USD) and Market Share by Region ( 2016-2021)
Table Global Female Contraception Drug Revenue Share (%) by Region ( 2016-2021)
Figure Revenue Market Share of Female Contraception Drug by Region ( 2016-2021)
Figure Global Female Contraception Drug Revenue Market Share by Region in 2020
Table Global Female Contraception Drug Sales Volume (K Pcs) and Market Share by Application ( 2016-2021)
Table Global Female Contraception Drug Sales Share (%) by Application ( 2016-2021)
Figure Sales Market Share of Female Contraception Drug by Application ( 2016-2021)
Figure Global Female Contraception Drug Sales Market Share by Application ( 2016-2021)
Figure United States Female Contraception Drug Sales (K Pcs) and Growth Rate ( 2016-2021)
Figure United States Female Contraception Drug Revenue (Million USD) and Growth Rate ( 2016-2021)
Figure United States Female Contraception Drug Sales Price (USD/Pcs) Trend ( 2016-2021)
Table United States Female Contraception Drug Sales Volume (K Pcs) by Players ( 2016-2021)
Table United States Female Contraception Drug Sales Volume Market Share by Players ( 2016-2021)
Figure United States Female Contraception Drug Sales Volume Market Share by Players in 2020
Table United States Female Contraception Drug Sales Volume (K Pcs) by Type ( 2016-2021)
Table United States Female Contraception Drug Sales Volume Market Share by Type ( 2016-2021)
Figure United States Female Contraception Drug Sales Volume Market Share by Type in 2020
Table United States Female Contraception Drug Sales Volume (K Pcs) by Application ( 2016-2021)
Table United States Female Contraception Drug Sales Volume Market Share by Application ( 2016-2021)
Figure United States Female Contraception Drug Sales Volume Market Share by Application in 2020
Figure Europe Female Contraception Drug
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Research Allied ™ Copyright © 2025 .